Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL30423108

CCOc1nc(N2CCN(C(=O)OC(C)(C)C)CC2)ncc1C(=O)Nc1cc(OC)c2nc(C)cn2c1.O=C(O)C(F)(F)F

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PTPN11 Q06124 3/20 0.50
▸ MAPT P10636 5/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ GPR119 Q8TDV5 1/20 0.39
▸ TLR9 Q9NR96 2/20 0.38
▸ TLR7 Q9NYK1 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ SCD O00767 1/20 0.38
▸ SCD5 Q86SK9 1/20 0.38
▸ TP53 P04637 1/20 0.37
▸ NR3C1 P04150 1/20 0.37
▸ DGAT1 O75907 1/20 0.37
▸ SMPD3 Q9NY59 1/20 0.36
▸ ATM Q13315 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30423031 0.96 PTPN11 (0.52) PTPN11MAPTMEN1TSHRKMT2A
SCHEMBL30423084 0.85 PTPN11 (0.50) PTPN11MAPTMEN1TSHRKMT2A
SCHEMBL30423033 0.83 PTPN11 (0.54) PTPN11MAPTMEN1TSHRKMT2A
SCHEMBL25419558 0.82 MAPT (0.45) PTPN11MAPT
SCHEMBL31485489 0.82 MAPT (0.45) PTPN11MAPT
SCHEMBL30422149 0.82 MAPT (0.40) PTPN11MAPTMEN1KMT2AGPR119
SCHEMBL30422594 0.80 AAK1 (0.39) PTPN11MAPT
SCHEMBL30422689 0.80 PTPN11 (0.42) PTPN11MAPTMEN1TSHRKMT2A
SCHEMBL25421861 0.80 PTPN11 (0.42) PTPN11MAPTMEN1TSHRKMT2A
SCHEMBL25438924 0.79 PTPN11 (0.50) PTPN11MAPTMEN1TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4441042-A1 5-PYRIMIDINECARBOXAMIDE DERIVATIVES AND METHODS OF USING THE SAME Rgenta Therapeutics, Inc. (US) 2024-10-09 — — EP disclosed
WO-2023102231-A1 5-PYRIMIDINECARBOXAMIDE DERIVATIVES AND METHODS OF USING THE SAME RGENTA THERAPEUTICS, INC. (US) 2023-06-08 — — WO disclosed
Send feedback